ask="7.27"
ask_size="500"
average_daily_volume="880594"
bid="7.03"
bid_size="800"
book_value="0.05"
change="+0.20"
change_from_200_day_moving_average="2.57"
change_from_50_day_moving_average="1.05"
change_from_52_week_high="-1.70"
change_From_52_week_low="5.50"
change_in_percent="+2.89%"
close="7.13"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.91"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.83"
ex_dividend_date="N/A"
float_shares="46288000"
high="7.22"
high_52_weeks="8.83"
last_trade_date="1/6/2017"
last_trade_price="7.13"
last_trade_size="47228"
last_trade_time="4:00pm"
low="6.91"
low_52_weeks="1.63"
market_capitalization="525.89M"
moving_average_200_day="4.56"
moving_average_50_day="6.08"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.08"
open="6.91"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+56.49%"
percent_change_from_50_day_moving_average="+17.25%"
percent_change_from_52_week_high="-19.25%"
percent_change_from_52_week_low="+337.42%"
previous_close="6.93"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="128.33"
price_per_sales="23.26"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="13.23"
stock_exchange="NMS"
symbol="BCRX"
volume="1034888"
weeks_range_52="1.63 - 8.83"
